REQUEST A DEMO
Total
USD $0.00
Search more companies

Melopharma Sas (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Melopharma Sas Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Melopharma Sas is based in Colombia. The head office is in Zipaquira. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on June 05, 2020. There are currently 1 (2024) people employed by Melopharma Sas. The company’s latest financial report indicates a net sales revenue increase of 3.63% in 2023. Over the same period, its total assets grew by 273.6%. In, 2023, the company’s net profit margin decreased by 1.78%.

Headquarters
Parque Industrial Zuma Bodega 105 Km 1 Via Zipaquira Ubate
Zipaquira; Cundinamarca;

Contact Details: Purchase the Melopharma Sas report to view the information.

Basic Information
Total Employees:
Purchase the Melopharma Sas report to view the information.
Outstanding Shares:
Purchase the Melopharma Sas report to view the information.
Incorporation Date:
June 05, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Melopharma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
3.63%
Total operating revenue
3.63%
Operating profit (EBIT)
-17.97%
Net Profit (Loss) for the Period
-17.97%
Total assets
273.6%
Total equity
33.19%
Operating Profit Margin (ROS)
-2.74%
Net Profit Margin
-1.78%
Return on Equity (ROE)
-15.54%
Quick Ratio
-16.85%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?